Study Medications included The true value of teratogenic risk (%) The perceived value of teratogenic risk (%) The perceived value compared to the true value of teratogenic risk
Lupattelli et al. thalidomide 10 to 40 Low health literacy: 84.5 Over-estimated
Medium health literacy: 89.5 Over-estimated
High health literacy: 94.8 Over-estimated
Gils et al. thalidomide 20 to 50 GP: 20 Properly-estimated
OB/GYN: 20 Properly-estimated
warfarin 10 to 20 GP: 3 Under-estimated
OB/GYN: 5 Under-estimated
retinoids 30 to 38 GP: 10 Under-estimated
OB/GYN: 5 Under-estimated
Nordeng et al. thalidomide 10 to 40 All included women: 75 Over-estimated
Damase-Michel et al. sodium valproate 10 All healthcare professionals: 41.8 Over-estimated
lithium 12 All healthcare professionals: 55.8 Over-estimated
isotretinoin 25 All healthcare professionals: 89 Over-estimated
warfarin 30 All healthcare professionals: 58.7 Over-estimated
thalidomide 50 All healthcare professionals: 91.7 Over-estimated
Sanz et al. phenytoin ≤ 10 Physicians: 37.9 Over-estimated
Clinical students: 41.3 Over-estimated
Pre-clinical students: 58.9 Over-estimated
Non-pregnant women: 67.9 Over-estimated
Pregnant women: 59.5 Over-estimated
warfarin 6 to 25 Physicians:53.2 Over-estimated
Clinical students: 44.6 Over-estimated
Pre-clinical students: 63.1 Over-estimated
Non-pregnant women: 68.4 Over-estimated
Pregnant women: 42.8 Over-estimated
etretinate 16 to 30 Physicians: 95.9 Over-estimated
Clinical students: 55.1 Over-estimated
Pre-clinical students: 59.7 Over-estimated
Non-pregnant women: 45.8 Over-estimated
Pregnant women: 16.4 Properly-estimated
thalidomide 11 to 35 Physicians: 81.6 Over-estimated
Clinical students: 73.4 Over-estimated
Pre-clinical students: 79.3 Over-estimated
Non-pregnant women: 91.1 Over-estimated
Pregnant women: 82.6 Over-estimated
Pons et al. misoprostol >3 Non-pregnant women: 50 Properly-estimated
Pregnant women: 50 Properly-estimated
Petersen et al. thalidomide 10 to 40 All included women: 94 Over-estimated